Tianjin Zhong Xin Pharmaceutical Group Corporation Limited on Monday said it expects to report a 50 to 70 per cent increase in year on year net profit for the fiscal half year ended June 30, 2012.
The company expects to record a gain on disposal of the Company's subsidiary, being Tianjin Central Pharmaceutical Co Ltd, an increase in the return on investment from the company's associated companies and increase in operating profits from the group's main business.
A year ago, the group posted a net profit of 194.97 million yuan (US$30.88 million), and earnings per share of 0.26 yuan.
The group is in the process of finalising its unaudited half year results.
.jpg)
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited on Monday said it expects to report a 50 to 70 per cent increase in year on year net profit for the fiscal half year ended June 30, 2012.
